Sites to Upload Raw Dna Data for Medication Analysis
Across Beginnings Genetics
Plow Your 23andMe raw data into professionally reviewed medical results
Using your 23andMe raw data, you can get the same type of professionally analyzed and reviewed genetic screening that your physician might order.
The ActX medical screening offers: - Improved accuracy (estimation past a CAP accredited laboratory that has washed a validation of the raw data)
- Confirmation of serious risks by a second exam (Sanger)
- Medical view for your physician with the most up to date medically accepted clinical decision back up available
- Possible fiscal coverage through your HSA/FSA accounts
How ActX differs from Dna raw data analysis sites like Promethease
ActX has carefully validated the 23andMe raw data, and uses only probes that accept been shown to piece of work. A squad of geneticists, genetic counselors, and pharmD's carefully curates the variants and creates the content, which focuses on actionable items. A contempo peer reviewed study (one) has shown that sites like Promethease return results that can contain up to twoscore% false positives for serious conditions. ActX is far more than authentic and confirms all serious findings with a second test. Your doc will receive truly useful and actionable content.What you and your doc go:
Prescription review (Pharmacogenomics)
Prescription review, also known as pharmacogenomics, can automatically alert your physician when writing your prescription that, based on your genetics, the medication may be ineffective, cause serious side effects or require different dosing, allowing them to prescribe a amend culling.
99% of people have genetic variants that volition affect how their medications work
The 23andMe Ancestry version covers no medications. The ActX analysis contains much more all-encompassing medication coverage than the 23andMe Health + Beginnings version.
Hereditary Risk
Hereditary hazard genetic screening can identify actionable hereditary risks for certain cancers, types of cardiovascular disease and other weather prior to whatsoever symptoms. ActX only screens for hereditary risks where there is scientific evidence that something can be done to reduce the hazard or severity of the condition. Medical experts agree that this is the best approach for doctors and patients and non-actionable risks should not exist screened for.
three-iv% of patients have actionable genetic risks that tin be addressed by a physician
The 23andMe Ancestry version covers no risks. The ActX analysis contains much more extensive risk coverage than the 23andMe Wellness + Ancestry.
Carrier Status
Carrier status covers recessive genetic conditions that yous have a 25% chance to laissez passer on to your children if both you and your partner have it.
sixty% of people who plan to have children volition accept at least one genetic condition they potentially could pass on to their children
The 23andMe Ancestry version does non embrace carrier status. The ActX analysis contains much more extensive carrier status coverage than the 23andMe Health + Ancestry.
Md's clinical conclusion support
With the amount of new genetic clinical bear witness coming out daily it is a challenge for any clinician to be upwards to date on the latest clinical information. ActX has adult the GenoACT℠ clinical review service that is constantly updated to provide data on your genetic variants with expanded educational material and the latest suggested clinical actions that you and your physician can have.
Pricing
For a limited time, the cost of the ActX analysis, including any confirmations of serious risks, is just $95.
Note
ActX interpretation of 23andMe raw data requires the authorization of a doc. Versions four and 5 of 23andMe testing, which are the latest versions, are currently supported. ActX is a screening service, and not intended for the diagnosis of high take a chance patients. The service looks only at selected variants (DNA variations) for the targeted genes and non all possible genetic variants. Just validated portions of the 23andMe raw data are used. Bachelor just to individuals xviii and older.
ActX is not affiliated with 23andMe. 23andMe is a trademark of 23andMe, Inc.
(one) Tandy-Connor et al., "False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient intendance", Genetics in Medicine Vol. 20, 1515–1521 (2018)
Source: https://www.actx.com/23andme_home
0 Response to "Sites to Upload Raw Dna Data for Medication Analysis"
Postar um comentário